Glycemic outcomes, insulin, and system use
SD
For the CAS cohort, mean ± standard deviation (SD) of A1C was determined. For both the CAS and real-world cohorts, the mean ± SD of percentage of time spent in AHCL; percentage of CGM use, mean SG, coefficient of variation (CV) of SG, glucose management indicator (GMI), and percentage of time spent at SG ranges (i.e., <54 mg/dL, <70 mg/dL, 70–180 mg/dL, >180 mg/dL and >250 mg/dL) for the 24-h day and nighttime (12:00 AM to 05:59 AM) were assessed. The mean ± SD of total daily dose of insulin (TDD), total basal insulin, total bolus insulin, and system-initiated insulin (including Auto Correction insulin) were also determined. Additional analyses included system use/interactions involving the daily number of AHCL exits, user-initiated boluses, and BGMs for the 24-h day.